PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes
复制标题
DOI:
10.1016/j.celrep.2022.110331
复制
发表时间:
2022-02-01
期刊:
影响因子:
8.8
通讯作者:
Togashi, Yosuke
中科院分区:
文献类型:
--
作者:
Nagasaki, Joji;Inozume, Takashi;Togashi, Yosuke
PD-1 blockade exerts clinical efficacy against various types of cancer by reinvigorating T cells that directly attack tumor cells (tumor-specific T cells) in the tumor microenvironment (TME), and tumor-infiltrating lymphocytes (TILs) also comprise nonspecific bystander T cells. Here, using single-cell sequencing, we show that TILs include skewed T cell clonotypes, which are characterized by exhaustion (T-ex) or nonexhaustion signatures (Tnon-ex). Among skewed clonotypes, those in the T-ex, but not those in the Tnon-ex, cluster respond to autologous tumor cell lines. After PD-1 blockade, non-preexisting tumor-specific clonotypes in the T-ex cluster appear in the TME. Tumor-draining lymph nodes (TDLNs) without metastasis harbor a considerable number of such clonotypes, whereas these clonotypes are rarely detected in peripheral blood. We propose that tumor-infiltrating skewed T cell clonotypes with an exhausted phenotype directly attack tumor cells and that PD-1 blockade can promote infiltration of such T-ex clonotypes, mainly from TDLNs.